Bridgehealth, Inc.

BridgeHealth, Inc. operates as a healthcare solutions provider specializing in surgical care, focusing on affordability and quality. Their services streamline accessing surgical procedures for clients across various specialties. BridgeHealth, Inc.

is dedicated to facilitating high-quality surgical procedures. Founded in 2007 and headquartered in Denver, US, it has engaged in 2 significant deals, with the most recent being a Series A funding round on October 22, 2020. The company was founded by David Calone, who has an extensive background in healthcare solutions. BridgeHealth raised USD 40.

00 mn in its latest funding round from investors including 7wireVentures, Alta Partners, and General Catalyst Partners, which represents the total amount raised to date. BridgeHealth offers a specialized service called Transcarent Surgery Care, which focuses on facilitating a variety of surgical procedures such as general surgery, orthopedic, spine, women's health, cardiac, vascular, and bariatric surgery. The company employs Care Coordinators to assist clients throughout their healthcare journey, ensuring access to verified providers and addressing financial barriers associated with necessary surgical care. Their services primarily target clients in the United States, including both individuals seeking surgical options and employers aiming to enhance health benefits for employees.

BridgeHealth generates revenue by providing surgical care at reduced out-of-pocket costs for its clients. The company works on a direct-to-consumer model and partners with employers and health plans to offer its services as part of their healthcare benefits. Although specific service costs are not disclosed, members benefit from lower fees for surgical procedures, ensuring value-driven care and competitive pricing while maintaining high-quality outcomes. Following the Series A funding round on October 22, 2020, BridgeHealth plans to utilize the USD 40.

00 mn raised to enhance its service offerings and expand its market reach. The company is actively developing new surgical care products and aims to enter additional geographic regions to cater to a broader audience. Specific details on the proposed launch dates and targeted new markets are currently under strategic planning.